## INSURANCE APPLICATION FORM - REVISED LEGAL LIABILITY INSURANCE FOR CLINICAL TRIALS

DATE:

/

/

1. Contracting Party:

The Sponsor(s)

In the capacity of:

Address:

Telephone:

Fax:

Email:

The Investigator(s):

In the capacity of:

Address:

Telephone:

Fax:

Email:

2. Description of Business:

3. Date Business was established:

4. Contracting Party acts as agent of another party:

- (Indicate if not applicable)

5. Hospital(s) and/or Institution(s) where the trials are to be performed:

6. Title(s) of the Trial(s) for which insurance is sought:

Phase:   I

- [ ] II

- [ ] III

Other:

7. No. of Trial Subjects:

8. Status of Helsinki Committee approvals:

Local: Approval Ministry of Health

Date:

Expiration:

Date:

Expiration:

9. Date the Trial is to begin:

10. Date the Trial is to end:

- [ ] no

11. Are all trials are to be conducted in full accordance with: (please give full details if any reply is 'No'):

- a. Public Health Regulations (Medical Experiments Involving  Human Subjects)--1980?

- [ ] Yes

- [ ] b. Protocols approved by the relevant Helsinki Committee(s) Including any special conditions required by a committee as a condition of approval? Yes

- [ ] No

- c. Ministry of Health--Pharmaceutical Division Guidelines of September, 1999?

- [ ] Yes

- [ ] No

- d. Any directive on Good Clinical Practice (GCP)? Which directive?

- [ ] Yes

- [ ] No

- e. A Consent Form to be signed by each Trial Subject conforming to those set forth in the: Ministry of Health-Pharmaceutical Division Guidelines of 1999?

- [ ] Yes

- [ ] No

12. If a medication, pharmaceutical or medical device is being investigated in the Trial(s), is product liability insurance in force?

- [ ] Yes

- [ ] No

13. All trials are to be conducted in Israel?

- [ ] Yes

- [ ] No

- If not, state other countries in which trials are to take place:

14. Has the study been approved by the national ethical committee in each trial country?

- [ ] Yes

- [ ] No

15. Is the clinical trial drug listed on the attached pharma exclusion list ?

- [ ] Yes

- [ ] No

16. Does the study involve surgical activity?

- [ ] Yes

- [ ] No

17. Inclusion criteria:

- Does the study include pregnant women?

- [ ] Yes

- [ ] No

- Does the trial involve women of child bearing potential who are not obliged to take any contraception measures?

- [ ] Yes

- [ ] No

- Does the study include children (&lt;18 years)?

- [ ] Yes

- [ ] No

- 1 18. Is the trial performed with invasive  medical devices/implants?

- [ ] Yes

- [ ] No

19. Is the route of administration intravenous/ 2 intra-arteriel/intrathecal ?

- [ ] Yes

- [ ] No

20. Does the study involve invasive removal and/or implantation of cells, organic tissue, organs, blood and/or bloodserum (beyond routine withdrawal of blood)?

- [ ] Yes

- [ ] No

21. Does the study involve any viruses, bacteria and/or cells that have been genetically modified?

- [ ] Yes

- [ ] No

22. Does the study involve gentherapy or stem cells?

- [ ] Yes

- [ ] No

23. Comments:

Please provide any additional comments on the trial.

- 24.

- Requested Limits of Liability USD per anyone claim / occurrence USD in the Aggregate during the period

of Insurance.

25. Give  details  of  incidents  during  the  last  5  years  resulting  in  death, injury,  disease  or  illness  (physical  or  mental)  to  patients  or  volunteers participating in similar or related clinical trials, and any circumstances which might give rise to a claim for compensation against the Contracting Party, the Sponsor, the Investigator or the manufacturer of the  medication  or  device  which  is  to  be  investigated  in  the  Trial  for which coverage is sought.

1 Relating to a technique in which the body is entered by puncture or incision

2 Describes the fluid-filled space between the thin layers of tissue that cover the brain and spinal cord. Drugs can be injected into the fluid or a sample of the fluid can be removed for testing.

Include  date  of  event,  date  of  claim,  description  of  injury,  amount  of claim, status and outcome.  (Attach a separate page if necessary)

26. If  not  included  in  the  Protocol  to  be  submitted  with  this  application, provide summary of similar or related Trials/Studies performed in the last  12  months. Include the dates, a description, the Phase of the Trial and  the  number  of  patients  or  volunteers  participating.  (Attach  a separate page if necessary):

27. For each trial to be insured, you must attach a copy of:

- A. Protocol or Summary of Protocol: (must be provided in English)

- B. Helsinki Committee (s) Approval (s) (may be in Hebrew)

- C. Patient Information/Explanation and Informed Consent Form to be used in the trial

I  hereby  declare  that  all  of  the  answers  above  are  correct,  complete  and straightforward and that I have not concealed any material facts relating to the trial(s) to be insured or the assessment of the risks involved.  I hereby acknowledge and agree that the information provided above will be relied upon by the insurance company and shall serve as a basis of the policy.

Signed on behalf of the Contracting Party:

Name:

Date:

Position:

This proposal is subject to review and written confirmation on behalf of the insurers and shall not be construed as an offer to insure.

Note: Attached Pharma exclusion list.

## Pharmaceutical products/substances exclusion list

| 8-Hydroxy-quinolines                       | -   | Mibefradil                                     |
|--------------------------------------------|-----|------------------------------------------------|
| Adalimumab                                 | -   | Nefazodone                                     |
| Alatrofloxacin                             | -   | Olanzapine                                     |
| Alosetron                                  | -   | Parecoxib                                      |
| Amiodarone                                 | -   | Paroxetine                                     |
| Apomorphine                                | -   | Phentermine                                    |
| Astemizole                                 | -   | Phenylpropanolamine (PPA)                      |
| Benzbromarone                              | -   | Pioglitazone                                   |
| Bromfenac                                  | -   | Piper methysticum (Kava-Kava)                  |
| Bromocriptine                              | -   | Rapacuronium                                   |
| Bupropion (also known as amfebutamone)     | -   | Remoxipride                                    |
| Butorphanol                                | -   | Risperidone                                    |
| Celecoxib                                  | -   | Rofecoxib                                      |
| Cerivastatin                               | -   | Rosiglitazone                                  |
| Cisapride                                  | -   | Selective Norepinephrine                       |
| Contraceptives, side effects               |     | Reuptake Inhibitors (SNRI)                     |
| Dex, -Fenfluramine/Phentermine (PHEN- FEN) | -   | Selective Serotonin Reuptake Inhibitors (SSRI) |
| Diethylstilbestrol (DES)                   | -   | Sibutramine                                    |
| Encainide                                  | -   | Sildenafil                                     |
| Ephedrine / Pseudoephedrine                | -   | Statins including combined                     |
| Etanercept Etoricoxib                      |     | ingestion with fibrates                        |
|                                            | -   | Sumatriptan                                    |
| Flosequinan                                | -   | Tadalafil                                      |
| Fluoxetine                                 | -   | Temafloxacin                                   |
| Grepafloxacin                              | -   | Terbinafine                                    |
| Hormone Replacement Therapeutics (HRT),    | -   | Terfenadine                                    |
| 'box warning' side effects                 | -   | Thalidomide                                    |
| Infliximab                                 |     |                                                |
| Isotretinoin                               | -   | Theophyllin                                    |
| Itraconazole                               | -   | Thimerosal/Thiomersal                          |
| Leflunomide                                | -   | Troglitazone                                   |
| Levomethadyl                               | -   | Trovafloxacin                                  |
| Levonorgestrel (marketed as OTC)           | -   | Valdecoxib                                     |
| LYMErix vaccine                            | -   | Vardenafil                                     |
| Methylphenidate (MPH)                      |     |                                                |